---
title: Presentation and diagnosis of secondary diabetes causes
videoId: 4mCO2RlhyyE
---

From: [[marrowmed]] <br/> 

Diabetes can manifest due to various underlying conditions, referred to as secondary causes. Recognizing these causes is crucial for accurate diagnosis and management, especially in cases that do not fit the typical presentation of common diabetes types.

## Case Scenario Indicating Secondary Diabetes <a class="yt-timestamp" data-t="00:00:06">[00:00:06]</a>

A 63-year-old female presented with a four-year history of uncontrolled diabetes. This short duration of uncontrolled diabetes in an elderly patient is atypical for [[metabolic_disorders_in_biochemistry_for_neet_pg_exam | Type 2 Diabetes Mellitus]] (DM), which often manifests earlier and progresses over decades. <a class="yt-timestamp" data-t="00:00:28">[00:00:28]</a>, <a class="yt-timestamp" data-t="00:00:34">[00:00:34]</a>, <a class="yt-timestamp" data-t="00:02:44">[00:02:44]</a>.

Key symptoms presented by the patient include:
*   Ulcerating rash on the shin, groin, and face <a class="yt-timestamp" data-t="00:00:52">[00:00:52]</a>
*   Stomatitis and glossitis <a class="yt-timestamp" data-t="00:00:58">[00:00:58]</a>
*   Worsening symptoms for four years despite specialized wound care <a class="yt-timestamp" data-t="00:01:01">[00:01:01]</a>
*   Severe weight loss <a class="yt-timestamp" data-t="00:01:05">[00:01:05]</a>
*   Abdominal pain <a class="yt-timestamp" data-t="00:01:07">[00:01:07]</a>
*   Intractable nausea <a class="yt-timestamp" data-t="00:01:09">[00:01:09]</a>

Additionally, the patient showed no signs of typical diabetic complications like [[diabetic_retinopathy_complications | retinopathy]], nephropathy, or neuropathy. <a class="yt-timestamp" data-t="00:01:47">[00:01:47]</a>. The presence of skin lesions and zinc deficiency further points away from typical Type 2 DM. <a class="yt-timestamp" data-t="00:01:52">[00:01:52]</a>, <a class="yt-timestamp" data-t="00:01:56">[00:01:56]</a>.

### Importance of Proper Diabetes Classification <a class="yt-timestamp" data-t="00:02:05">[00:02:05]</a>
When diagnosing diabetes, it is essential to determine the specific type (e.g., Type 1, LADA, Type 2, MODY, Type 3, pancreatic diabetes, or secondary causes). Hyperglycemia is a phenotypic manifestation, but the underlying pathology must be understood. <a class="yt-timestamp" data-t="00:02:09">[00:02:09]</a>, <a class="yt-timestamp" data-t="00:02:26">[00:02:26]</a>, <a class="yt-timestamp" data-t="00:02:31">[00:02:31]</a>.

## Common Secondary Causes of Diabetes <a class="yt-timestamp" data-t="00:03:14">[00:03:14]</a>
For examination purposes, common secondary causes to consider include:
*   **Hemochromatosis:** Can present with diabetes as part of its clinical manifestations. <a class="yt-timestamp" data-t="00:03:24">[00:03:24]</a>.
*   **IgG4-related disease:** May lead to pancreatic diabetes and other pancreatic manifestations. <a class="yt-timestamp" data-t="00:03:29">[00:03:29]</a>.
*   **Carcinoma of the Pancreas (CA Pancreas):** Especially in the elderly, diabetes can be a presenting symptom. <a class="yt-timestamp" data-t="00:03:34">[00:03:34]</a>.
*   **[[understanding_neuroendocrine_tumors_and_pancreatic_conditions | Neuroendocrine Tumors]] (NETs):** A very important consideration. <a class="yt-timestamp" data-t="00:03:39">[00:03:39]</a>.

### Pancreatic Neuroendocrine Tumors (PNETs) <a class="yt-timestamp" data-t="00:04:58">[00:04:58]</a>
PNETs are significant causes of secondary diabetes. They are classified based on the hormones they secrete.

#### Glucagonoma <a class="yt-timestamp" data-t="00:04:47">[00:04:47]</a>
The case described aligns strongly with **Glucagonoma**, a rare [[characteristics_and_symptoms_of_glucagonoma_and_somatostatinoma | neuroendocrine tumor]] of the pancreas, typically arising from the body and tail. <a class="yt-timestamp" data-t="00:05:11">[00:05:11]</a>. It is often a solitary, large lesion. <a class="yt-timestamp" data-t="00:05:31">[00:05:31]</a>.

**Clinical Features (5D's of Glucagonoma):**
1.  **Diabetes:** Rapidly worsening and often uncontrolled. <a class="yt-timestamp" data-t="00:06:39">[00:06:39]</a>, <a class="yt-timestamp" data-t="00:06:42">[00:06:42]</a>.
2.  **Deep Vein Thrombosis (DVT):** Patients are prone to thrombosis. <a class="yt-timestamp" data-t="00:06:44">[00:06:44]</a>, <a class="yt-timestamp" data-t="00:06:46">[00:06:46]</a>.
3.  **Depression:** <a class="yt-timestamp" data-t="00:07:04">[00:07:04]</a>.
4.  **Diarrhea:** <a class="yt-timestamp" data-t="00:07:09">[00:07:09]</a>.
5.  **Dermatitis:** Specifically, **Necrolytic Migratory Erythema (NME)**, an ulcerating rash, is a characteristic skin lesion. <a class="yt-timestamp" data-t="00:07:14">[00:07:14]</a>, <a class="yt-timestamp" data-t="00:07:17">[00:07:17]</a>.

**Associated Symptoms:**
*   **Severe Weight Loss:** A hallmark feature, primarily due to hypoaminoacidemia, where amino acids are used to form glucose, leading to a frail appearance and muscle mass loss. <a class="yt-timestamp" data-t="00:06:00">[00:06:00]</a>, <a class="yt-timestamp" data-t="00:06:07">[00:06:07]</a>, <a class="yt-timestamp" data-t="00:06:12">[00:06:12]</a>.
*   **Hypoalbuminemia:** Contributes to zinc deficiency, as albumin is a carrier for zinc, and proteins are utilized for glucose production. This can lead to features similar to acrodermatitis enteropathica, including glossitis and stomatitis. <a class="yt-timestamp" data-t="00:02:22">[00:02:22]</a>, <a class="yt-timestamp" data-t="00:07:27">[00:07:27]</a>, <a class="yt-timestamp" data-t="00:07:50">[00:07:50]</a>, <a class="yt-timestamp" data-t="00:07:54">[00:07:54]</a>.
*   **Glucagonoma Triad:** Necrolytic Migratory Erythema, weight loss, and abdominal pain. <a class="yt-timestamp" data-t="00:07:36">[00:07:36]</a>, <a class="yt-timestamp" data-t="00:07:42">[00:07:42]</a>.

#### Somatostatinoma <a class="yt-timestamp" data-t="00:03:51">[00:03:51]</a>
[[characteristics_and_symptoms_of_glucagonoma_and_somatostatinoma | Somatostatinoma]] is another [[understanding_neuroendocrine_tumors_and_pancreatic_conditions | neuroendocrine tumor]] that can cause diabetes. <a class="yt-timestamp" data-t="00:03:59">[00:03:59]</a>. It typically arises from the duodenum. <a class="yt-timestamp" data-t="00:04:09">[00:04:09]</a>.

**Clinical Triad of Somatostatinoma:**
*   Diabetes <a class="yt-timestamp" data-t="00:04:14">[00:04:14]</a>
*   Cholelithiasis <a class="yt-timestamp" data-t="00:04:14">[00:04:14]</a>
*   Steatorrhea <a class="yt-timestamp" data-t="00:04:14">[00:04:14]</a>

**Key Distinguishing Features:**
*   **Mild Diabetes:** Somatostatinoma produces only mild diabetes because somatostatin inhibits glucagon secretion, preventing severe hyperglycemia. <a class="yt-timestamp" data-t="00:04:23">[00:04:23]</a>, <a class="yt-timestamp" data-t="00:04:25">[00:04:25]</a>.
*   **No Skin Lesions:** Unlike glucagonoma, somatostatinoma does not cause characteristic skin lesions. <a class="yt-timestamp" data-t="00:04:39">[00:04:39]</a>.
*   **Association:** Often associated with [[neurofibromatosis_type_1 | Neurofibromatosis Type 1]]. <a class="yt-timestamp" data-t="00:04:05">[00:04:05]</a>, <a class="yt-timestamp" data-t="00:04:51">[00:04:51]</a>, <a class="yt-timestamp" data-t="00:10:07">[00:10:07]</a>.

#### Other PNETs <a class="yt-timestamp" data-t="00:09:56">[00:09:56]</a>
*   **Insulinoma:** Most common sporadic pancreatic [[understanding_neuroendocrine_tumors_and_pancreatic_conditions | neuroendocrine tumor]]. <a class="yt-timestamp" data-t="00:10:05">[00:10:05]</a>. Prognosis is generally good, but can be worse when associated with MEN syndromes. <a class="yt-timestamp" data-t="00:13:58">[00:13:58]</a>.
*   **Gastrinoma:** Most common functional PNET in MEN1 and MEN4 syndromes. <a class="yt-timestamp" data-t="00:09:58">[00:09:58]</a>, <a class="yt-timestamp" data-t="00:10:00">[00:10:00]</a>. Sporadic gastrinomas have a poorer prognosis with high metastasis rates, while MEN1-associated gastrinomas tend to be smaller, more numerous, and have a better prognosis. <a class="yt-timestamp" data-t="00:13:08">[00:13:08]</a>, <a class="yt-timestamp" data-t="00:14:05">[00:14:05]</a>.

### Carcinoid Syndrome <a class="yt-timestamp" data-t="00:10:41">[00:10:41]</a>
Certain NETs, particularly midgut and foregut carcinoids, can produce large amounts of serotonin, kallikrein, bradykinin, and histamine, leading to carcinoid syndrome. <a class="yt-timestamp" data-t="00:10:22">[00:10:22]</a>, <a class="yt-timestamp" data-t="00:10:41">[00:10:41]</a>.

**Manifestations of Carcinoid Syndrome:**
*   Flushing (due to kallikrein) <a class="yt-timestamp" data-t="00:10:52">[00:10:52]</a>, <a class="yt-timestamp" data-t="00:11:02">[00:11:02]</a>
*   Bronchospasm (due to histamine) <a class="yt-timestamp" data-t="00:10:54">[00:10:54]</a>, <a class="yt-timestamp" data-t="00:11:04">[00:11:04]</a>
*   Diarrhea (due to serotonin) <a class="yt-timestamp" data-t="00:10:57">[00:10:57]</a>, <a class="yt-timestamp" data-t="00:11:07">[00:11:07]</a>

**Prognostic Significance:**
*   In midgut or pancreatic NETs, carcinoid syndrome typically only occurs with hepatic metastasis, as the liver usually clears these mediators from portal circulation. <a class="yt-timestamp" data-t="00:11:29">[00:11:29]</a>, <a class="yt-timestamp" data-t="00:12:01">[00:12:01]</a>.
*   Thymic carcinoids, being in systemic circulation, can cause carcinoid syndrome more readily. <a class="yt-timestamp" data-t="00:11:44">[00:11:44]</a>.

**Complications of Carcinoid Syndrome:**
*   **Right-sided Cardiac Involvement:** Most important complication, leading to right-sided heart failure. <a class="yt-timestamp" data-t="00:12:47">[00:12:47]</a>.
*   **Tricuspid Vegetation:** Most common valvular disease associated with carcinoid syndrome. <a class="yt-timestamp" data-t="00:12:51">[00:12:51]</a>.
*   **Niacin Deficiency:** Tryptophan is diverted for serotonin production, leading to niacin deficiency. <a class="yt-timestamp" data-t="00:12:28">[00:12:28]</a>.

### Genetic Syndromes Associated with PNETs <a class="yt-timestamp" data-t="00:09:21">[00:09:21]</a>
Several genetic syndromes can be associated with pancreatic neuroendocrine tumors:
*   MEN1 <a class="yt-timestamp" data-t="00:09:23">[00:09:23]</a>, <a class="yt-timestamp" data-t="00:09:40">[00:09:40]</a>
*   MEN4 (due to CDKN1B gene) <a class="yt-timestamp" data-t="00:09:23">[00:09:23]</a>, <a class="yt-timestamp" data-t="00:09:40">[00:09:40]</a>
*   VHL (Von Hippel-Lindau disease) <a class="yt-timestamp" data-t="00:09:23">[00:09:23]</a>
*   Tuberous Sclerosis <a class="yt-timestamp" data-t="00:09:23">[00:09:23]</a>
*   NF1 (Neurofibromatosis Type 1) <a class="yt-timestamp" data-t="00:09:23">[00:09:23]</a>

## Diagnostic Investigations for PNETs <a class="yt-timestamp" data-t="00:13:37">[00:13:37]</a>
*   **Somatostatin Receptor Scintigraphy (SRS):** The investigation of choice for almost all pancreatic [[understanding_neuroendocrine_tumors_and_pancreatic_conditions | neuroendocrine tumors]]. <a class="yt-timestamp" data-t="00:13:39">[00:13:39]</a>.
*   **Endoscopic Ultrasound (EUS):** Effective for detecting insulinomas and small gastrinomas (especially those associated with MEN1). <a class="yt-timestamp" data-t="00:13:44">[00:13:44]</a>, <a class="yt-timestamp" data-t="00:13:46">[00:13:46]</a>.

While surgery is often preferred for localized tumors, many PNETs, like glucagonomas, present with metastases, making surgical resection challenging. <a class="yt-timestamp" data-t="00:13:32">[00:13:32]</a>, <a class="yt-timestamp" data-t="00:14:35">[00:14:35]</a>.